微导管在原发性肝癌介入治疗中的应用价值

目的:探讨微导管在原发性肝癌化疗性栓塞中的应用价值。方法:应用微导管对29例原发性肝癌患者行供血动脉超选择化疗栓塞术。结果:本组29例共行化疗性栓塞41次,术后血清AFP下降大于50%者24例(82.8%),肿瘤缩小>50%者6例(20.7%),肿瘤缩小在25%～50%者16例(55.2%),其余患者肿瘤体积无明显变化。术后肝功能损害轻微,无严重并发症。结论:微导管超选择插管治疗肝癌操作简单、方便,超选择成功率高,疗效好,术后并发症少,具有十分重要的临床应用价值。

Value of Microcatheter in Interventional Treatment of Primary Hepatocarcinoma

Objective:To investigate the value of microcatheter in chemoembolization of primary hepatocarcinoma (PHC). Methods:Chemoembolization of feeding arteries of PHC was performed with microcatheter in 29 patients.Results:A total of 41 chemoembolization procedures were performed.Following transcatheter arterial chemoembolization (TACE),reduction of serum AFP over 50% was found in 24 patients (82.8%),while tumor volume reduction over 50% was found in 6 (20.7%),less than 50% but more than 25% in 16 (55.2%).The damage to liver function was slight and no serious complications occurred.Conclusion:With microcatheter,the manipulation of TACE is simpler and easier,with a higher rate of success,efficacy and less complications.Microcatheter has great value in TACE therapy for PHC.